Home
Home
About Us
Nav
Products
Nav
Partnership
Nav
CMO Services
Nav
Careers
Nav
Contact
Nav
Leadership
Milestones
Organizations
Global Locations
2019/03/08
PRINSTON PHARMACEUTICAL, RECEIVES FDA APPROVAL FOR GLYCOPYRROLATE INJECTION, 0.2 mg/mL
2019/03/08
PRINSTON ANNOUNCES THE FDA APPROVAL OF FENOFIBRATE TABLETS, 48mg and 145mg
2019/01/08
Prinston Pharmaceutical issues Voluntary Nationwide Recall of Irbesartan and Irbesartan HCTZ
Prev
1
Next
Archives
2018
2017
2016 2015
Quick Links
Home
About Us
Products
Partnership
Careers
Contact Us
Social Media
